Is 6817.TWO overvalued or undervalued?

6817.TWO currently has a P/E ratio of 10.22. Relative to the sector average of 26.70, this suggests the stock may be undervalued. A higher P/E than peers means investors are paying more for each unit of earnings, often because they expect faster future growth. However, if that growth does not materialize, the stock can appear overvalued. A lower P/E may indicate weaker growth expectations or higher risk, but it can also signal a potential valuation discount.

How can I buy Winston Medical Supply Co., Ltd. stock?

Winston Medical Supply Co., Ltd. trades on TWO. Investors in Latin America can buy it through international and regional brokerage and investment platforms. You simply need a valid government ID or passport to get started.

Can I buy fractional shares of 6817.TWO?

Yes. Through fractional investing, you can invest exactly the amount you want, starting with as little as $1 or $5 USD (depending on what investment platform you use), and own a proportional piece of the company.

Does buying 6817.TWO protect my money against local inflation?

Many investors in Latin America buy international stocks like 6817.TWO to protect their purchasing power. Because 6817.TWO is priced in foreign currency, your investment is tied to a hard currency. If your local currency devalues against the foreign currency, usually USD or Euro, the underlying value of your stock portfolio remains protected from local inflation.

Do I need a foreign bank account or a Visa to buy 6817.TWO shares?

No. A common misconception is that you need a foreign bank account or a foreign visa to invest in international stocks. Today, modern investment platforms allow you to fund your account using local bank transfers or local payment methods right from your home country.

Is 6817.TWO a suitable investment for my portfolio?

There is no universal answer, since fit depends on your situation, not just the stock. Think about three things: how well 6817.TWO diversifies what you already own, whether you can stomach its price swings given your risk tolerance, and how long you plan to stay invested. As a rule, a single stock works best as one piece of a broader asset allocation and with a multi-year time horizon. This is general information, not personalized financial advice.

All stocks6817.TWO

Winston Medical Supply Co., Ltd.

NT$45.80-NT$0.20-0.43%

TWO / TWD

Market cap

NT$843M

P/E

10.2

EPS (TTM)

NT$0.14

Dividend yield

10.92%

Beta

0.15

1Y return

-58.92%

Deposit US$200 and get US$50 for freeT&C apply. Your capital is at risk.Invest with

Compare, tap a companyup to 2 at once

Deposit US$200 and get US$50 for freeT&C apply. Your capital is at risk.Invest with

Financials

The numbers behind the company

Revenue vs net income

RevenueNet income

$19M2021

$20M2022

$23M2023

$21M2024

$22M2025

Financial health

Gross margin

Operating margin

ROE

ROA

Debt to equity0.19Low
Current ratio1.68
Cash ratio0.90
Net margin13.0%
Free cash flow—

Valuation

Is it expensive right now

P/E vs the market

scale 0–50

0153050

6817.TWO10.2
Healthcare sector median26.7
S&P 50022.0

Trades about 62% below its sector, cheaper than its peers on earnings.

Ratios

PEG-0.27
Price to book2.30
EPS (TTM)NT$0.14
Payout ratio15,633%
FCF yield9.07%

Range & risk

NT$40.15NT$112.00

Trading in the lower third of its 52-week band

Beta0.15

Profile

What Winston Medical Supply Co., Ltd. actually does

Winston Medical Supply Co., Ltd. is a firm dedicated to the creation, production, and distribution of a wide array of pharmaceutical goods, dietary supplements, and beauty-enhancing health products. Its diverse inventory includes sterile ophthalmic formulations, such as gels, liquid suspensions, solutions, and emulsions for eye care. The company also manufactures hormonal medications, specifically contraceptives and oral suspensions designed for managing cancer-related cachexia. Additionally, its product range features topical applications, including various ointments. A significant portion of its offerings consists of diverse oral medications provided in various forms like powders, lozenges (troches), standard tablets, film-coated tablets, chewable forms, and capsules. These are developed to treat ailments such as common colds, digestive system issues, and other specific medical conditions. Established in 1974, Winston Medical Supply Co., Ltd. is based in Tainan City, Taiwan, and operates as a subsidiary of Medigen Biotechnology Corp.

CEO

You-Zheng Wang

Employees

180

Headquarters

Tainan City, TQ

Founded

2021-02-24

Company website

If you had invested a decade ago

Loading the full price history…

Run your own numbers

Past performance is not a forecast.

ETFs

Own it inside an ETF instead

Vanguard S&P 500

Vanguard Total Stock Market

Vanguard Total World Stock

Invesco QQQ

SPDR S&P 500

iShares Russell 2000

Community sentiment

Bullish—

Distribution

Bearish0%
Neutral0%
Bullish0%

Track it without buyingTrack it

no account needed

Save 6817.TWO and get told when something moves.

Get updates

A clear, direct weekly summary.

Keep looking

Q&A

Questions people ask

6817.TWO has a beta of 0.15, which indicates how sensitive it has historically been to movements in its broader market. A beta below 1 indicates lower relative volatility than the market. Beta is based on historical data and does not predict future performance.

Winston Medical Supply Co., Ltd.